Add to your lists

Recommended Content

Picture of All-In Podcast

LA's Wildfire Disaster, Zuck Flips on Free Speech, Why Trump Wants Greenland

Jan. 11, 2025, 2:08 a.m.

No Paywall
Picture of Tech Investment Ideas

ASML's Strategy to Extend Moore's Law

Jan. 7, 2025, 9:50 a.m.

No Paywall
Picture of Platformer

OpenAI says it knows how to make superintelligence now

Jan. 7, 2025, 1:32 a.m.

Some Paywall
Picture of Tanay’s Newsletter

Comparing the Financials of Databricks and Snowflake

Dec. 30, 2024, 11:35 p.m.

No Paywall
Picture of The Entertainment Strategy Guy

The Future of TV or Just Another Netflix Hit?

Dec. 19, 2024, 12:10 a.m.

No Paywall
FinBrowser logo

How would you rate this source in terms of content quality?
Source Picture

Bio Stocks™

Picture of Bio Stocks™

Similiar Sources

Picture of Adam Feuerstein
Adam Feuerstein
Biotech - News 7.5
Picture of BioPharma Dive
BioPharma Dive
Biotech - News 8.0
Picture of Biopharma Reporter
Biopharma Reporter
Biotech - News 8.0
Picture of Cafepharma
Cafepharma
Biotech - News 8.0
Picture of Drug Delivery Business
Drug Delivery Business
Biotech - News 8.0
Picture of Drugs.com
Drugs.com
Biotech - News 8.0
Picture of Evaluate
Evaluate
Biotech - News 8.0
Picture of Fierce Biotech
Fierce Biotech
Biotech - News 8.0
Picture of GEN
GEN
Biotech - News 8.0
Picture of Labiotech
Labiotech
Biotech - News 8.0

Summary

Sector Biotech
Content Type News
Website Twitter
Paywall No

Ratings

Average Rating 8.0
Ratings 1
Your Rating Rate
Ranking 707

Content

Twitter Update

Hey there! Due to the recent policy changes implemented by Twitter, I regret to inform you that FinBrowser is currently unable to display any new Tweets. I know this might be disappointing, as Twitter is a valuable source of information and updates for many of us. However, I want to assure you that I am actively working on finding alternative solutions and exploring ways to reintegrate Twitter sources into this website. I appreciate your patience and understanding during this time of transition.
Picture of Bio Stocks™

$WETG volatility halt. ↑ 160%

June 14, 2023, 1:34 p.m.

No Paywall
Picture of Bio Stocks™

$LVTX the ongoing clinical trial of LAVA-051 targeting CD1d expressing hematological tumors, including multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and AML will be discontinued

June 14, 2023, 1:02 p.m.

No Paywall
Picture of Bio Stocks™

$NBSE announces 1-for-20 reverse split

June 14, 2023, 12:34 p.m.

No Paywall
Picture of Bio Stocks™

$PDSB Announces Achievement of Efficacy Threshold in Stage 2 of the VERSATILE-002 Trial Evaluating PDS0101 and KEYTRUDA in Head and Neck Cancer. 14 patients in the immune checkpoint inhibitor naïve arm of VERSATILE-002 have experienced either a CR or PR on two consecutive scans,…

June 14, 2023, 12:10 p.m.

No Paywall
Picture of Bio Stocks™

$KURA prices $100M offering. $5.66M shares + warrants at $11.50/share

June 14, 2023, 11:03 a.m.

No Paywall
Picture of Bio Stocks™

$TSVT Announces Clinical Study Pause of PLAT-08 Trial of SC-DARIC33 in AML. The pause was instituted as part of the clinical study protocol stopping rules in response to a recent Grade 5 (fatal) serious adverse event (SAE)

June 14, 2023, 11:01 a.m.

No Paywall
Picture of Bio Stocks™

$EGRX Receives Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for CAL02, Providing Five-Year Exclusivity Extension

June 14, 2023, 10:52 a.m.

No Paywall
Picture of Bio Stocks™

$RARE initiated at Outpefrom at Credit Suisse. PT $96

June 14, 2023, 10:11 a.m.

No Paywall
Picture of Bio Stocks™

$ATIP 1-for-50 reverse split

June 14, 2023, 10:09 a.m.

No Paywall
Picture of Bio Stocks™

$BIIB Biogen has been an uninvestable stock for a while - Mizuho.

June 13, 2023, 10:34 p.m.

No Paywall
Picture of Bio Stocks™

CPI (YoY) (May) 4% vs 4.1% Est. Core CPI (MoM) For May 0.4% Vs 0.4% Est.

June 13, 2023, 12:30 p.m.

No Paywall
Picture of Bio Stocks™

$ACRS Completes Enrollment in Phase 2b Study of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis. Topline Data in Q4

June 13, 2023, 11:12 a.m.

No Paywall
Picture of Bio Stocks™

$FWBI Reaches Enrollment Target for Phase 2 SPAN Adrulipase Clinical Trial in Cystic Fibrosis. Topline Data in July.

June 13, 2023, 11:01 a.m.

No Paywall
Picture of Bio Stocks™

$ETNB initiated with an Outperform at Evercore ISI. PT $49

June 13, 2023, 10:38 a.m.

No Paywall
Picture of Bio Stocks™

$AAPL downgraded to Neutral from Buy at UBS.

June 12, 2023, 11:49 p.m.

No Paywall
Picture of Bio Stocks™

$JPM JPMorgan Agrees to Settle Jeffrey Epstein Accusers’ Suit. Civil complaint had alleged bank facilitated Epstein’s sex-trafficking operation.

June 12, 2023, 12:17 p.m.

No Paywall
Picture of Bio Stocks™

$DAWN closes offering. Full exercise of 1.7M shares overallotment. Gross proceeds $172.5M

June 12, 2023, 12:10 p.m.

No Paywall
Picture of Bio Stocks™

$PHAT Announces FDA Acceptance of NDA Resubmission for Erosive GERD. Class 2 resubmission. PDUFA 11/17/23

June 12, 2023, 12:02 p.m.

No Paywall
Picture of Bio Stocks™

$SOFI PT raised to $11 at Truist

June 12, 2023, noon

No Paywall
Picture of Bio Stocks™

$AZN NDA for Capivasertib in combination with Faslodex granted Priority Review for patients with advanced HR-positive breast cancer. PDUFA Q4

June 12, 2023, 10:04 a.m.

No Paywall
Picture of Bio Stocks™

Can chatbots be ministers? Hundreds attend #ChatGPT led church service. #AI

June 11, 2023, 6:31 p.m.

No Paywall
Picture of Bio Stocks™

$IMGN PT raised to $20 at Barclays.

June 9, 2023, 1:23 p.m.

No Paywall
Picture of Bio Stocks™

$ABEO FDA requested additional assay data to establish comparability between RVV sourced from Indiana University and RVV manufactured in-house at Abeona. Co. has requested the pre-BLA meeting date for EB-101 be rescheduled for August. Expects to file BLA for EB-101 in Q3

June 9, 2023, 11:35 a.m.

No Paywall
Picture of Bio Stocks™

$ABEO Announces Regulatory Update on BLA for EB-101.

June 9, 2023, 11:32 a.m.

No Paywall
Picture of Bio Stocks™

$BIIB halted for AdComm

June 9, 2023, 11:22 a.m.

No Paywall